[{"address1": "355 Alhambra Circle", "address2": "Suite 801", "city": "Coral Gables", "state": "FL", "zip": "33134", "country": "United States", "phone": "305 420 3200", "website": "https://catalystpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizures; Ruzurgi for the treatment of pediatric LEMS patients; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.", "fullTimeEmployees": 181, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard John  Daly M.B.A.", "age": 63, "title": "President, CEO & Director", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 1435729, "exercisedValue": 0, "unexercisedValue": 2297505}, {"maxAge": 1, "name": "Mr. Michael W. Kalb CPA", "age": 53, "title": "Executive VP, Treasurer & CFO", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 996788, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven R. Miller Ph.D.", "age": 62, "title": "Executive VP, COO & Chief Scientific Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 926600, "exercisedValue": 0, "unexercisedValue": 15242348}, {"maxAge": 1, "name": "Mr. Jeffrey  Del Carmen", "age": 53, "title": "Executive VP & Chief Commercial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 862997, "exercisedValue": 0, "unexercisedValue": 7986267}, {"maxAge": 1, "name": "Dr. Preethi  Sundaram Ph.D.", "age": 48, "title": "Chief Strategy Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 753425, "exercisedValue": 0, "unexercisedValue": 3662612}, {"maxAge": 1, "name": "Ms. Mary  Coleman", "title": "VP & Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Elsbernd J.D.", "age": 60, "title": "Chief Compliance Officer & Chief Legal Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 311416, "exercisedValue": 0, "unexercisedValue": 107032}, {"maxAge": 1, "name": "Mr. Gregg  Russo", "title": "Chief Human Resources Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philip B. Schwartz Esq.", "age": 69, "title": "Corporate Secretary", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 4, "overallRisk": 6, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 25.36, "open": 25.65, "dayLow": 25.57, "dayHigh": 26.09, "regularMarketPreviousClose": 25.36, "regularMarketOpen": 25.65, "regularMarketDayLow": 25.57, "regularMarketDayHigh": 26.09, "payoutRatio": 0.0, "beta": 0.718, "trailingPE": 16.477707, "forwardPE": 17.13245, "volume": 1201138, "regularMarketVolume": 1201138, "averageVolume": 1261682, "averageVolume10days": 1090880, "averageDailyVolume10Day": 1090880, "bid": 25.83, "ask": 25.91, "bidSize": 3, "askSize": 2, "marketCap": 3155493376, "fiftyTwoWeekLow": 14.75, "fiftyTwoWeekHigh": 26.16, "priceToSalesTrailing12Months": 5.9020233, "fiftyDayAverage": 23.7736, "twoHundredDayAverage": 22.13355, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2577932288, "profitMargins": 0.36912, "floatShares": 112883124, "sharesOutstanding": 121975000, "sharesShort": 7425676, "sharesShortPriorMonth": 7788333, "sharesShortPreviousMonthDate": 1744675200, "dateShortInterest": 1747267200, "sharesPercentSharesOut": 0.060900003, "heldPercentInsiders": 0.062179998, "heldPercentInstitutions": 0.83381, "shortRatio": 7.23, "shortPercentOfFloat": 0.0779, "impliedSharesOutstanding": 121975000, "bookValue": 6.513, "priceToBook": 3.972056, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "earningsQuarterlyGrowth": 1.438, "netIncomeToCommon": 197351008, "trailingEps": 1.57, "forwardEps": 1.51, "enterpriseToRevenue": 4.822, "enterpriseToEbitda": 9.577, "52WeekChange": 0.6551503, "SandP52WeekChange": 0.119305134, "quoteType": "EQUITY", "currentPrice": 25.87, "targetHighPrice": 40.0, "targetLowPrice": 31.0, "targetMeanPrice": 34.0, "targetMedianPrice": 33.0, "recommendationKey": "none", "numberOfAnalystOpinions": 8, "totalCash": 580656000, "totalCashPerShare": 4.76, "ebitda": 269168992, "totalDebt": 3091000, "quickRatio": 5.848, "currentRatio": 6.142, "totalRevenue": 534646016, "debtToEquity": 0.389, "revenuePerShare": 4.469, "returnOnAssets": 0.18591999, "returnOnEquity": 0.29114, "grossProfits": 446456000, "freeCashflow": 223082128, "operatingCashflow": 267926000, "earningsGrowth": 1.368, "revenueGrowth": 0.436, "grossMargins": 0.83505, "ebitdaMargins": 0.50345004, "operatingMargins": 0.44807, "financialCurrency": "USD", "symbol": "CPRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Catalyst Pharmaceuticals, Inc.", "longName": "Catalyst Pharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1162996200000, "postMarketChangePercent": 0.695397, "postMarketPrice": 26.0499, "postMarketChange": 0.17989922, "regularMarketChange": 0.51, "regularMarketDayRange": "25.57 - 26.09", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1261682, "fiftyTwoWeekLowChange": 11.120001, "fiftyTwoWeekLowChangePercent": 0.7538984, "fiftyTwoWeekRange": "14.75 - 26.16", "fiftyTwoWeekHighChange": -0.289999, "fiftyTwoWeekHighChangePercent": -0.011085589, "fiftyTwoWeekChangePercent": 65.51503, "earningsTimestamp": 1746648894, "earningsTimestampStart": 1754424000, "earningsTimestampEnd": 1754942400, "earningsCallTimestampStart": 1746707400, "earningsCallTimestampEnd": 1746707400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 1.57, "epsForward": 1.51, "epsCurrentYear": 2.10062, "priceEpsCurrentYear": 12.315412, "fiftyDayAverageChange": 2.0964012, "fiftyDayAverageChangePercent": 0.0881819, "twoHundredDayAverageChange": 3.7364502, "twoHundredDayAverageChangePercent": 0.16881387, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1749254382, "regularMarketTime": 1749240001, "exchange": "NCM", "messageBoardId": "finmb_5103575", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.01104, "regularMarketPrice": 25.87, "displayName": "Catalyst Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-06-07"}]